Sort by
Refine Your Search
-
– James is the only cancer program in the United States that features a National Cancer Institute (NCI)-designated comprehensive cancer center aligned with a nationally ranked academic medical center and a
-
the effects of dynamic shaking on physical properties. The Post Doctoral Scholar will embark on a program of independent research with the primary goal of undrained shear experiments on natural seafloor
-
provided by the Ohio Eminent Scholars program. This is a term position for an initial period of one year with the possibility of renewal based on performance and availability of funding. For inquiries
-
University studying microbial ecology of glacier and permafrost environments. The Post Doctoral Scholar will embark on a program of independent research with the primary goal of determining how microorganisms
-
references, and one or more writing samples (published or in press). Materials should be attached to the application and sent electronically to Dr. Raeshan Davis, Research Scientist and HHMI Program Manager
-
motivated researcher with a strong background in computational modeling, system identification, and uncertainty quantification for civil infrastructure. The successful candidate will join the Risk Assessment
-
program of independent research with the primary goal of improving the algorithm codes used to characterize the Earth’s gravitational field. Duties will include specialized scientific/numerical analysis
-
. Previous experience in clinical research is desirable, particularly patient-oriented research. Additional Information: The OSUCCC – James is the only cancer program in the United States that features a
-
-employment physical including a drug screen. Additional Information: The focus of the NIH research program is on “Mechanotransduction and Mechanical Stress induced Postoperative ileus” (POI). The goal is to
-
member of the Oncology Research Information Exchange Network (ORIEN) Robust clinical trials program with active translational therapeutics that include a clinical research unit, Phase 1 U01 grant and N01